Dr Reddy's Laboratories Ltd Stock News

Dr Reddys Venlafaxine ER Tablets are available in 150 mg and 225 mg strengths in bottle count sizes of 30 and 90.

Mumbai, December 9 Equity benchmark Sensex opened on a choppy note on Thursday, as investors followed the risk-off mode. The 30-share index opened over 200 points higher, but soon turned negative and was trading 38.52 points or 0.07 per cent lower at 58,611.16 in initial deals. Similarly, the Nifty slipped 17.60 points or 0.10 per cent to 17,452.15. Reliance Industries was the top gainer in the Sensex pack, rising over 1 per cent, followed by Dr Reddy''s, Asian Paints, Sun Pharma, Lamp;T, Bajaj Finance, Infosys and HDFC. On the other hand, HDFC Bank, Tata Steel, NTPC, TCS and Titan were among the laggards. In the previous session, the 30-share equity benchmark zoomed 1,016.03 points or 1.76 per cent to finish at 58,649.68, and Nifty rallied 293.05 points or 1.71 per cent to 17,469.75. Foreign institutional investors remained net sellers in the capital market, as they sold shares worth Rs 579.27 crore on Wednesday, as per exchange data. Elsewhere in Asia, bourses in Shanghai, Seoul and Hong Kong were trading with gains in mid-session deals, while Tokyo was in the red.

The global Pantoprazole Sodium market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is

Mumbai, November 26 The Sensex nosedived 1,688 points while the Nifty slumped below the 17,100-level on Friday as a new and potentially vaccine-resistant coronavirus variant sent shockwaves through global markets. The variant, detected in South Africa, Botswana and Hong Kong so far, has an unusual combination of mutations, as per initial reports. Countries like Britain and Japan have already imposed travel restrictions, raising the spectre of a fresh wave of lockdowns. The Sensex plummeted 1,687.94 points or 2.87% to close at 57,107.15 following an across-the-board selloff. Similarly, the Nifty plunged 509.80 points or 2.91% to 17,026.45. Currency markets too were not spared, with the rupee sinking 37 paise versus the US dollar, in tandem with other emerging market currencies. IndusInd Bank was the top loser in the Sensex pack, tanking 6.01%, followed by Maruti, Tata Steel, NTPC, Bajaj Finance, HDFC and Titan. Only four counters managed to close in the green Dr Reddy''s, Nestle India, Asian Paints and TCS, spurting up to 3.32%.

BENGALURU: Indian shares sank nearly 3% on Friday as fears that a new, possibly vaccine-resistant coronavirus variant could wreak more economic damage prompted investors to dump equities globally. The blue-chip NSE Nifty 50 index ended down 2.91% at 17,026.45 and the benchmark S&P BSE Sensex closed 2.87% lower at 57,107.15, both marking their biggest daily drops since April 12. The losses also pushed the Nifty 50 to its worst weekly performance since late January, with both the main indexes losing over 4% this week to move further away from a record high struck in October. Markets globally were lower after scientists said the new variant detected in South Africa has an unusual combination of mutations, may be able to evade immune responses and could be more transmissible. That led India to tighten COVID-19 testing for tourists. "Nervousness on the new variant and expectations of the US increasing the pace of tapering have led to recent market weakness," Amit Gupta, fund manager at PMS at ICICI Securities, said in a note.

RDY, FRO, WWW, PGR, and LGIH have been added to the Zacks Rank #5 (Strong Sell) List on November 22, 2021.

RDY, FRO, WWW, PGR, and LGIH have been added to the Zacks Rank #5 (Strong Sell) List on November 22, 2021.

Sensex ended 314.04 points lower at 60,008 and Nifty fell 100.55 points to 17,898. Axis Bank was the top Sensex loser, shedding 1.95 per cent, followed by Reliance Industries, Kotak Bank, Bharti Airtel, Titan, Dr Reddy''s and M&M.

Dr. Reddy's Laboratories Ltd (NYSE: RDY) said it was open to making Pfizer Inc's (NYSE: PFE) COVID-19 antiviral pill, Reuters reported. The new drugs can be used to treat patients once they contrac

ALX, RDY, HSC, LAWS, and ANDE have been added to the Zacks Rank #5 (Strong Sell) List on November 4, 2021.

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. R

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. R

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. R